A multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of daily oral administration of SH T00660AA for the treatment of endometriosis over 12 weeks
Phase of Trial: Phase III
Latest Information Update: 13 Jan 2009
At a glance
- Drugs Dienogest (Primary)
- Indications Endometriosis
- Focus Registrational; Therapeutic Use
- 17 Nov 2005 New trial record.